VICENTI ILARIA | Elenco docenti

Rossi, S., Deidda, G., Fiaschi, L., Ibba, R., Pieroni, M., Dichiara, M., et al. (2025). Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3. ARCHIV DER PHARMAZIE, 358(1) [10.1002/ardp.202400812]. - dettaglio
Martina, M.G., Vagaggini, C., Dreassi, E., De Angelis, M., Nencioni, L., Dragoni, F., et al. (2025). Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-14001-3]. - dettaglio
Amodeo, D., Marchi, S., Fiaschi, L., Raucci, L., Biba, C., Salvestroni, V., et al. (2025). Analysis of the SARS-CoV-2 inactivation mechanism using violet-blue light (405 nm). APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 91(6) [10.1128/aem.00403-25]. - dettaglio
Giammarino, F., Paletti, C., Bartolini, N., Fiaschi, L., Biba, C., Varasi, I., et al. (2025). Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro. ANTIVIRAL RESEARCH, 239 [10.1016/j.antiviral.2025.106157]. - dettaglio
Biba, C., Fiaschi, L., Varasi, I., Paletti, C., Bartolini, N., Zazzi, M., et al. (2024). A Comparison of Sanger Sequencing and Amplicon-Based Next Generation Sequencing Approaches for the Detection of HIV-1 Drug Resistance Mutations. VIRUSES, 16(9) [10.3390/v16091465]. - dettaglio